Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Burton Malkiel Insider Profile
4 Followers
Burton Malkiel, Director at Theravance Biopharma, holds 115.59K shares in Theravance Biopharma (Ticker: TBPH), holds 41.00K shares in Innoviva (Ticker: INVA).
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+34.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Burton Malkiel holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 18, 2015 - Aug 18, 2016
Return:+122.80%
The most profitable trade made by Burton Malkiel
Burton Malkiel's Trading History
Theravance Biopharma
May 04, 2023
Director
Uninformative Buy
―
$1.09M
Innoviva
May 27, 2014
Director
Uninformative Buy
―
$623.20K
List of latest transactions for each holding click on a transaction to see Burton Malkiel's performance on stock
You May Also Like
Burton Malkiel insider profile FAQ
What is the percentage of profitable transactions made by Burton Malkiel?
The percentage of profitable transactions made by Burton Malkiel is 33%.
What is the average return per transaction made by Burton Malkiel?
The average return per transaction made by Burton Malkiel is 34.00%.
What stocks does Burton Malkiel hold?
Burton Malkiel holds: TBPH, INVA stocks.
What was Burton Malkiel’s latest transaction?
Burton Malkiel latest transaction was an Uninformative Buy of ―.
What was Burton Malkiel's most profitable transaction?
Burton Malkiel’s most profitable transaction was an Informative Buy of TBPH stock on August 18, 2015. The return on the trade was 122.80%.
What is Burton Malkiel's role in Theravance Biopharma?
Burton Malkiel's role in Theravance Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.